Today: 4 February 2026
Subscribe
Browse Category

NYSE:MANE News 4 February 2026

Veradermics IPO Pops Above Range as Eli Lilly Lines Up a 5% Stake Play

Veradermics IPO Pops Above Range as Eli Lilly Lines Up a 5% Stake Play

NEW YORK, Feb 4, 2026, 07:08 (EST) Veradermics, the biopharma working on an oral hair-loss treatment, set its IPO price at $17 a share, above the initial range, pulling in roughly $256.3 million. The stock is slated to start trading Wednesday on the New York Stock Exchange under the ticker “MANE.” (Seekingalpha) The deal may be modest by Wall Street…
4 February 2026
·····

Stock Market Today

  • AppLovin Stock Falls 30% in January amid Short-Seller Attacks and AI Concerns
    February 4, 2026, 11:04 AM EST. AppLovin's shares dropped 30% in January following renewed short-seller allegations and rising concerns over the impact of Google's AI game platform, Project Genie. Despite a strong 2025 where the stock doubled, doubts about its valuation at a price-to-sales ratio of 31 and an ongoing SEC investigation weighed on investor sentiment. The stock plunged 17% on the last trading day after the AI platform launch, hitting a sector-wide sell-off. Analysts remain cautiously optimistic ahead of AppLovin's Q4 earnings due Feb. 11, projecting 17% revenue growth to $1.61 billion and earnings per share rising to $2.95. Market watchers note the shift from mobile game development to adtech monetization, suggesting the sell-off may be disproportionate and premature.
Go toTop